BioNTech SE - ADR vs Cincinnati Financial Corporation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Cincinnati Financial Corporation trades at $173.45 (market cap $26.58B). The key difference: BioNTech SE - ADR and Cincinnati Financial Corporation are close in size by market cap, and Cincinnati Financial Corporation pays a 2.17% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | CINF | |
|---|---|---|
Market Cap | $23.31B | $26.58B |
Sector | Health | Financials |
52-Week High | $119.34 | $192.03 |
52-Week Low | $83.89 | $149.79 |
Enterprise Value | $6.60B | $25.71B |
Dividend Yield | — | 2.17% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Read more on CINF →